Susquehanna International Group
AST

Susquehanna International Group’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Susquehanna International Group’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-33,900
Closed -$115K – 10487
2017
Q3 		$115K Sell
33,900
-11,200
-25% -$37.7K ﹤0.01% 8311
2017
Q2 		$160K Buy
45,100
+19,300
+75% +$63.6K ﹤0.01% 8459
2017
Q1 		$88K Sell
25,800
-1,000
-4% -$3.89K ﹤0.01% 8442
2016
Q4 		$123K Buy
+26,800
New +$111K ﹤0.01% 8982

Susquehanna International Group's AST Position: Q4 2018 in Review

Susquehanna International Group sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2018, closing a stake of 60,989 shares — an estimated $63.3K sold.

Susquehanna International Group first reported a position in AST in Q1 2015 and held it in 11 quarters. The position peaked at $368K in Q4 2017. 46 funds tracked by Wall St. Rank hold AST as of Q4 2018.

  • Susquehanna International Group reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2018 after selling out during the quarter.
  • Susquehanna International Group sold 60,989 Asterias Biotherapeutics Inc. Series A shares in Q4 2018, an estimated $63.3K.
  • Susquehanna International Group first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2015 and held it in 11 quarters.
  • Susquehanna International Group's Asterias Biotherapeutics Inc. Series A position peaked at $368K in Q4 2017.
  • 46 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2018.

Based on Susquehanna International Group's 13F filing for Q4 2018, filed 14 Feb 2019.